The Scientist

» evolution, immunology and disease/medicine

Most Recent

image: The Wada Test, 1948

The Wada Test, 1948

By | November 1, 2017

A decades-old neurological procedure developed under unique and difficult conditions in postwar Japan remains critical to the treatment of epilepsy.

0 Comments

image: These Flies Hijack Frogs’ Love Calls

These Flies Hijack Frogs’ Love Calls

By | November 1, 2017

The phenomenon is one of the few examples of eavesdropping across the vertebrate/invertebrate barrier.

1 Comment

image: These Flies Suck. . . Frogs

These Flies Suck. . . Frogs

By | November 1, 2017

Insects feast on amorous tungara frogs by eavesdropping on their amphibian love songs.

0 Comments

image: Tracking Invasive Fire Ants in Asia

Tracking Invasive Fire Ants in Asia

By | November 1, 2017

These insect transplants have the potential to wreak economic havoc by outcompeting native insects and destroying crops.

0 Comments

image: Getting Drugs Past the Blood-Brain Barrier

Getting Drugs Past the Blood-Brain Barrier

By | November 1, 2017

To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.

3 Comments

Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

image: The Weird Growth Strategy of Earth’s First Trees

The Weird Growth Strategy of Earth’s First Trees

By | October 24, 2017

Ancient fossils reveal how woodless trees got so big: by continuously ripping apart their xylem and knitting it back together.

1 Comment

image: Genetic Risk Factors for Breast Cancer Identified

Genetic Risk Factors for Breast Cancer Identified

By | October 23, 2017

Researchers identify 72 novel genetic variants associated with breast cancer risk.

0 Comments

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS